Antimicrobial Resistance (AMR) is one of the world’s leading causes of illness and death, causing misery to millions every year. As part of a new series, we are featuring stories of patients who have been affected by AMR, as told to Antibiotic Research UK. In this story, Annabelle explains how a superbug infection took hold following a horse-riding accident.

In 2015 the World Health Assembly endorsed the Global Action Plan on antimicrobial resistance (AMR) calling on countries to develop and implement national action plans on AMR. Last week, WHO published an implementation handbook, offering guidance for the human health sector.

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance (AMR). In this post, Dr Christopher J.L. Murray, lead author of the landmark Global Research on Antimicrobial Resistance (GRAM) report, explores both tracking and tackling antimicrobial resistance around the world.

Antimicrobial Resistance (AMR) is one of the world’s leading causes of illness and death, causing misery to millions every year. As part of a new series, we are featuring stories of patients who have been affected by AMR, as told to Antibiotic Research UK. In this story, Ronda’s experience of how a catheter-acquired UTI after surgery has become resistant to antibiotic treatment and changed her life completely.

Ahead of our forthcoming ‘Into Clinical Practice: Pneumonia’ conference, Professor Mervyn Singer, Professor of Intensive Care Medicine & Chair of the International Sepsis Forum, University College London and Dr Ron Daniels BEM, Executive Director of the UK Sepsis Trust, discuss the challenge of balancing the risk of sepsis with the threat of antimicrobial resistance (AMR).

BSAC has joined the Infection Management Coalition (IMC), which brings together industry and charity leaders to help transform the way infection is detected, monitored, prevented, and managed, underpinned by the establishment of a global network of hospital-based, community-based and mobile laboratories to track the spread of antimicrobial resistance (AMR).

Infectious intestinal diseases affect 1 in 5 people in the UK each year. Ahead of her talk at BSAC’s upcoming Infection Clinical Dilemmas webinar, Marisa Lanzman explores her thoughts and opinions on this important and sometimes controversial topic.

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance (AMR). In this post, Dr Amy Chang and Jonathan H. Chen MD PhD, explore the role artificial intelligence can play in tackling AMR…